Home Careers Site Map Contact Us
Company History < About Us < Home
About Us   Company History
1989 : Incorporated
1995 : Current management took over the company and started manufacturing Intermediates at Taloja
1997 : Forward Integrated into Manufacturing of Active Pharmaceutical Ingredients
2000 : Went Public with offering of 25% Shares. Set up a R&D Centre for development of API's & Intermediates.
2001 : Initiated exports to Non regulated market
2007 : Commissioned Sate of Art Formulation Unit for manufacturing Oral Solid Dosages at Dehradoon. Target at offering contract manufacturing services for all market including the regulated markets like Europe ,U.S.A. & Australia
2009 :
  • Set Up new division ‘SA-FORD’ [Sanctuary for Research and Development] with a focus on Toxicology Studies. The lab was set up with experienced leadership by German Scientist. The lab is now OECD GLP certified
  • Set up modern API plant [Unit – 2] with focus on the more regulated markets. The plant is now WHO-GMP Certified
2010 – 2011 :
  • The Dehradoon unit was approved by UK-MHRA, TGA-Australia, Canada - & Several other agencies
  • API Unit -2 was granted first CEP product – Trimetazidine Dihydrochloride . Several other DMF’s have been filed at EDQM
  • Three DMF Ketoconazole, Memantine HCl , Nifedipine were filed with USFDA
2014 : API Unit 2 gets GMP Certification from KFDA & EDQM.
website designers mumbai